No black box warning on record for Bizengri

As of the latest FDA labeling reviewed, Bizengri (ZENOCUTUZUMAB) does not carry a black box warning. Standard warnings and precautions still apply — see the full Bizengri medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Infusion-Related Reactions (IRR)/Hypersensitivity/Anaphylactic Reactions : Administer BIZENGRI in a setting with emergency resuscitation equipment and staff who are trained to monitor for IRRs and to administer emergency medications. Monitor for signs and symptoms of IRR. Interrupt infusion in patients with ≤ Grade 3 IRRs and administer symptomatic treatment as needed. R

No black box warning on record for Bizengri

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Infusion-Related Reactions (IRR)/Hypersensitivity/Anaphylactic Reactions : Administer BIZENGRI in a setting with emergency resuscitation equipment and staff who are trained to monitor for IRRs and to administer emergency medications. Monitor for signs and symptoms of IRR. Interrupt infusion in patients with ≤ Grade 3 IRRs and administer symptomatic treatment as needed. R

Bizengri Black Box Warning

No black box warning on record for Bizengri

Other warnings & precautions

Bizengri Black Box Warning

No black box warning on record for Bizengri

Other warnings & precautions